13-21671788-C-CTT
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_002010.3(FGF9):c.-118_-117dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.31 ( 8570 hom., cov: 0)
Exomes 𝑓: 0.34 ( 50112 hom. )
Consequence
FGF9
NM_002010.3 5_prime_UTR
NM_002010.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.911
Genes affected
FGF9 (HGNC:3687): (fibroblast growth factor 9) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein was isolated as a secreted factor that exhibits a growth-stimulating effect on cultured glial cells. In nervous system, this protein is produced mainly by neurons and may be important for glial cell development. Expression of the mouse homolog of this gene was found to be dependent on Sonic hedgehog (Shh) signaling. Mice lacking the homolog gene displayed a male-to-female sex reversal phenotype, which suggested a role in testicular embryogenesis. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 13-21671788-C-CTT is Benign according to our data. Variant chr13-21671788-C-CTT is described in ClinVar as [Benign]. Clinvar id is 311416.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.396 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGF9 | NM_002010.3 | c.-118_-117dup | 5_prime_UTR_variant | 1/3 | ENST00000382353.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGF9 | ENST00000382353.6 | c.-118_-117dup | 5_prime_UTR_variant | 1/3 | 1 | NM_002010.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.306 AC: 46276AN: 151444Hom.: 8575 Cov.: 0
GnomAD3 genomes
AF:
AC:
46276
AN:
151444
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.343 AC: 311357AN: 908188Hom.: 50112 Cov.: 13 AF XY: 0.344 AC XY: 161039AN XY: 468510
GnomAD4 exome
AF:
AC:
311357
AN:
908188
Hom.:
Cov.:
13
AF XY:
AC XY:
161039
AN XY:
468510
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.305 AC: 46264AN: 151560Hom.: 8570 Cov.: 0 AF XY: 0.307 AC XY: 22757AN XY: 74052
GnomAD4 genome
AF:
AC:
46264
AN:
151560
Hom.:
Cov.:
0
AF XY:
AC XY:
22757
AN XY:
74052
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Symphalangism-brachydactyly syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at